← 返回专利悬崖列表
CAS 39085-59-1
2,4,6-Triisopropylbenzenesulfonohydrazide
登记编号：(XLIV)101438-55-d、(VIII)101438-60-a、(VII)101438-76-a、(III)101438-78-a
应用背景（按来源药适应症）
乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate
来源药（使用该中间体的合成路线）
| 品种 | 梯队 | 到期年 |
|---|---|---|
| Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylate | Tier C · 观察 / 贸易 | - |
合成路线中的位置（上下游链）
按路线登记顺序排列，左→右为合成方向；高亮为当前 CAS，其余可点击跳转对应档案。
1,3-Dihydroxy-2,2-dimethylpropane→2,2-Dimethylcyclohexane-1,3-dione→2,2,4-Trimethylcyclohex-3-en-1-one→2,4,6-Triisopropyl-N'-[(1Z)-2,2,4-trimethylcyclohex-3-en-1-ylidene]benzenesulfonohydrazide→2,4,6-Triisopropylbenzenesulfonohydrazide→3,3,7,7-Tetramethyl-1,5-dioxaspiro[5.5]undecan-8-one→3,3,7,7,9-Pentamethyl-1,5-dioxaspiro[5.5]undec-8-ene→3,5-Cyclohexanedione→4-Methyl-N'-[(8E)-3,3,7,7-tetramethyl-1,5-dioxaspiro[5.5]undec-8-ylidene]benzenesulfonohydrazide→4-Methylbenzenesulfonhydrazide→Iodomethane
(S)-(+)-3,4,8,8a-Tetrahydro-8a-methyl-1,6(2H,7H)-naphthalenedione→(4aS,5S)-5-Hydroxy-4a-methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one→(4aS,5S)-4a-Methyl-5-[(triethylsilyl)oxy]-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one→3-[(1R,6S)-1-Methyl-2-oxo-6-[(triethylsilyl)oxy]cyclohexyl]propanoic acid→N'-[(2S,4aS,8aS)-2-Methoxy-4a-methyloctahydro-5H-1-benzopyran-5-ylidene]-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide→S-Ethyl 3-[(1R,6S)-1-methyl-2-oxo-6-[(triethylsilyl)oxy]cyclohexyl]propanethioate→(2S,4aR,8aS)-2-Hydroxy-4a-methyloctahydro-5H-1-benzopyran-5-one→(2S,4aR,8aS)-2-Methoxy-4a-methyloctahydro-5H-1-benzopyran-5-one→2,4,6-Triisopropylbenzenesulfonohydrazide→5-Methyl-2-(2-methylpent-3-yn-2-yl)-2-[(trimethylsilyl)oxy]hex-4-enal→(1S,2S)-1-[(2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-1-benzopyran-5-yl]-5-methyl-2-(2-methylpent-3-yn-2-yl)hex-4-ene-1,2-diol→(4S,5S)-5-[(2S,4aS,8aS)-2-Methoxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-1-benzopyran-5-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one→(4S,5S)-5-[(4aS,8aS)-2-Hydroxy-4a-methyl-3,4,4a,7,8,8a-hexahydro-2H-1-benzopyran-5-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one→(4S,5S)-5-[(5S,6S)-5-Hydroxy-6-(3-hydroxypropyl)-6-methylcyclohex-1-en-1-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one→(4S,5S)-5-[(5S,6S)-5-Hydroxy-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one→(4S,5S)-5-[(5S,6S)-5-[(Benzyloxy)methoxy]-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one
5-Hexenyl bromide→1-Phenyltetrazoline-5-thione→5-[(Hex-5-en-1-yl)sulfanyl]-1-phenyl-1H-tetrazole→5-(Hex-5-ene-1-sulfonyl)-1-phenyl-1H-tetrazole→1-Methyl-2-oxocyclohexane-1-carbaldehyde→2-Methyl-2-(octa-1,7-dien-1-yl)cyclohexan-1-one→2,4,6-Triisopropylbenzenesulfonohydrazide→N'-[2-Methyl-2-(octa-1,7-dien-1-yl)cyclohexylidene]-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide
2-(Hydroxymethyl)-2-methylcyclohexan-1-one→2-[(Ethoxymethoxy)methyl]-2-methylcyclohexan-1-one→2,4,6-Triisopropylbenzenesulfonohydrazide→N'-[2-[(Ethoxymethoxy)methyl]-2-methylcyclohexylidene]-2,4,6-tri(propan-2-yl)benzene-1-sulfonohydrazide→(4S*,5S*)-7-Ethenyl-4-[(6S*)-6-(hydroxymethyl)-6-methylcyclohex-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one→(1S*)-3-Ethenyl-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-ene-1-carbaldehyde→(S*)-[(1S*)-3-Ethenyl-2,2,4-trimethyl-1-[(trimethylsilyl)oxy]cyclohex-3-en-1-yl][(6R)-6-[(ethoxymethoxy)methyl]-6-methylcyclohex-1-en-1-yl]methanol→(1S*)-3-Ethenyl-1-[(S*)-[(6R*)-6-[(ethoxymethoxy)methyl]-6-methylcyclohex-1-en-1-yl](hydroxy)methyl]-2,2,4-trimethylcyclohex-3-en-1-ol→(4S*,5S*)-7-Ethenyl-4-[(6S*)-6-[(ethoxymethoxy)methyl]-6-methylcyclohex-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one→(1R*)-2-[(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]-1-methylcyclohex-2-ene-1-carbaldehyde→5-(Hex-5-ene-1-sulfonyl)-1-phenyl-1H-tetrazole→(4S*,5S*)-7-Ethenyl-4-[(6S*)-6-[hepta-1,6-dien-1-yl]-6-methylcyclohex-1-en-1-yl]-6,6,8-trimethyl-1,3-dioxaspiro[4.5]dec-7-en-2-one
本站可供应的对应中间体
目录暂未收录该靶点的在售中间体 —— 可直接发起询价，需求会进入撮合池。
本页为中间体 CAS 注册档案：同 CAS 的多条路线登记已合并；后续供应商报价与买方需求以该 CAS 为主键撮合。